Aclaris Therapeutics, Inc. (35) | Business Finance (8)
Browse by Subcategory
Recent Contracts
-
Underwriting Agreement by and among Aclaris Therapeutics, Inc., Jefferies LLC, SVB Leerink LLC and Piper Sandler & Co., dated June 9, 2021
(Filed With SEC on June 11, 2021)
-
Purchase Agreement, dated as of August 13, 2020, by and between the Company and Lincoln Park
(Filed With SEC on August 13, 2020)
-
Registration Rights Agreement, dated as of August 13, 2020, by and between the Company and Lincoln Park
(Filed With SEC on August 13, 2020)
-
Loan and Security Agreement, by and among the Company, Confluence Discovery Technologies, Inc. and Silicon Valley Bank, dated as of March 30, 2020
(Filed With SEC on March 31, 2020)
-
Warrant to Purchase Stock, issued to Silicon Valley Bank, dated as of March 30, 2020
(Filed With SEC on March 31, 2020)
-
Underwriting Agreement by and among Aclaris Therapeutics, Inc., Cantor Fitzgerald & Co. and William Blair & Company, L.L.C., dated January 20, 2021
(Filed With SEC on January 22, 2021)
-
Asset Purchase Agreement, by and between the Company and EPI Health, LLC, dated as of October 10, 2019
(Filed With SEC on October 11, 2019)
-
Loan and Security Agreement, dated as of October 15, 2018, by and among Oxford Finance LLC, the lenders party thereto, the Registrant, Confluence Discovery Technologies, Inc. and...
(Filed With SEC on March 18, 2019)